Tumor-Specific Expression of Organic Anion-Transporting Polypeptides: Transporters as Novel Targets for Cancer Therapy
Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Theresia Thalhammer(Medical University of Vienna), Andreas G. Tzakos(University of Ioannina), Lena Secky(Medical University of Vienna), Walter Jaeger(University of Vienna), Valentinos Kounnis(Churchill Hospital), Katrin Wlcek(University Hospital Zurich), Martin Svoboda(Medical University of Vienna), Evangelos Briasoulis
Cited by 108
Related Papers
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
|Blood|2011|448
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
|The Lancet Haematology|2020|351
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
|Blood Cancer Journal|2015|273